The biopharmaceutical industry is undergoing rapid growth and is challenged to deliver multi-modality products to a patient-centric global market. However, this requires a significant transformation in strategy, technology, R&D, and manufacturing.
This is where BioPhorum Technology Strategy will play a leading role.
BioPhorum Technology Strategy is the new name for BioPhorum Technology Roadmapping, which originated in 2015 from the need to address emerging biopharmaceutical industry challenges and opportunities. Eight years later, and after publishing our overarching Technology Roadmap 2.0 we recognized that roadmapping activities were largely complete and we needed the Phorum to transition to its next Technology Strategy phase.
Building on the original initiatives, BioPhorum Technology Strategy portfolio offers members realizable benefits spanning a timeline from one year to 10, depending on whether the focus of activity is proofs-of-concept, technology acceleration or further roadmapping.
The refreshed Phorum also offers benefits from a broader BioPhorum perspective, such as enhanced connectivity with the Information Technology, Sustainability, and Drug Substance Phorums. Enhanced membership models working across Technology Strategy and related phorums are now available including the newly launched Analytical and Instrument Providers. As a member, you will be able to realize benefits directly in your own organization, including:
- Increased plant asset utilization
- Reduced time for plant reconfiguration
- Increased speed to market
- Reduced cost of goods
- Increased quality of supply
- Reduced material usage and waste.
The Phorum’s portfolio will initially focus on three priority areas:
- Ultimate facility design (multi-modal and towards ‘lights out’ manufacture)
- Autonomous and advanced process control
- Knowledge management for future manufacturing.
BioPhorum Technology Strategy will continue to be the home for innovation for stakeholders across the eco-system and technology readiness levels. Our team comes from 50+ member organizations and has 600+ thought leaders and subject matter experts from biomanufacturers and suppliers, including analytical instrument, engineering, and automation providers. It will also continue collaborating with regulators, standards agencies, academics, and innovation hubs to provide innovative technological solutions to enable flexible and resilient end-to-end biomanufacturing.
The first BioPhorum Technology Strategy face-to-face Steering Committee meeting will be held on the US East Coast in May and will be co-located with Drug Substance to explore synergies and find collaborative opportunities. The new Phorum’s Analytical Provider, Engineering Partner, and Robotics and Automation Provider memberships are also building connections at a cross-phorum level.
BioPhorum Technology Strategy seeks to grow and strengthen roadmapping activities aligned with industry megatrends, progress the Digital Technology Roadmap 2.0, and Robotics and Automation activities for ‘lights out’ manufacture. We will also continue to identify areas for proof-of-concept to demonstrate the technical and business feasibility of solutions. Technology adoption will be accelerated through access to resources such as podcasts, white papers, blueprints, adoption frameworks, standards, and digital assets.
How are you accelerating your technology transformation and adoption?
If you would like to get involved in any aspects of the Phorum or to find out more, please get in touch with Andrea Johnston, PhD, BioPhorum Technology Strategy Director, at email@example.com